PharmGen Science Inc (004720) — Capital Reinvestment Ratio
Latest as of September 2025:
0.42x
PharmGen Science Inc (004720) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.91 Billion) in capital expenditures (₩799.96 Million). See cash generation quality of PharmGen Science Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.42x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.91 Billion
KRW
Capital Expenditures
₩799.96 Million
KRW
Data as of
Sep 2025
Most recent filing
PharmGen Science Inc Capital Reinvestment Ratio (2011–2024)
This chart tracks PharmGen Science Inc's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for PharmGen Science Inc (2011–2024)
Year-by-year Capital Reinvestment Ratio for PharmGen Science Inc from 2011 to 2024. For live market cap and broader valuation context, see 004720 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | ₩2.38 Billion | ₩2.78 Billion | ▲ +92.9% |
| 2023 | 0.61x | ₩5.44 Billion | ₩3.29 Billion | ▼ -84.7% |
| 2021 | 3.95x | ₩7.78 Billion | ₩30.75 Billion | ▲ +143.6% |
| 2020 | 1.62x | ₩2.68 Billion | ₩4.34 Billion | ▼ -33.6% |
| 2019 | 2.44x | ₩2.52 Billion | ₩6.16 Billion | ▲ +1053.3% |
| 2018 | 0.21x | ₩4.22 Billion | ₩892.34 Million | ▼ -74.7% |
| 2017 | 0.84x | ₩1.84 Billion | ₩1.54 Billion | ▲ +88.9% |
| 2016 | 0.44x | ₩7.75 Billion | ₩3.43 Billion | ▲ +107.8% |
| 2015 | 0.21x | ₩3.62 Billion | ₩771.87 Million | ▼ -4.0% |
| 2011 | 0.22x | ₩2.89 Billion | ₩642.43 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow